Davern Capital Partners, LP
Filing Date
Global Rank
#3,483
/ 8,795
▲ 510
· as of Jun 2026
Top Industry
Biotechnology
92.7%
3Y Alpha vs SPY
-9.3%
Period ended 3 months ago
Filed Aug 13, 2026 · 54d
3 quarters · since Dec 2025
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
15 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
12.0%
−0.3 pts
Top 5
55.7%
+9.8 pts
Top 10
86.8%
+6.1 pts
HHI
874
Diversified+125
Portfolio Trend
3 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $586,539,465 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | +1,059,506 | 1,932,904 | $68,405,472 | |
| RPRX | Royalty Pharma plc | +635,800 | 1,155,809 | $64,806,210 | |
| BNTX | BioNTech SE | +449,495 | 754,550 | $70,210,877 | |
| IONS | Ionis Pharmaceuticals Inc | +411,806 | 798,709 | $63,329,636 | |
| MLYS | Mineralys Therapeutics, Inc. | +411,600 | 858,753 | $23,169,155 | |
| INSM | INSMED Inc | +377,262 | 559,824 | $59,688,434 | |
| GPCR | Structure Therapeutics Inc. | +319,598 | 446,059 | $23,939,986 | |
| GENB | Generate Biomedicines, Inc. | +232,879 | 824,679 | $13,912,334 | |
| PRCT | PROCEPT BioRobotics Corp | +203,720 | 464,920 | $10,497,893 | |
| REGN | Regeneron Pharmaceuticals, Inc. | +47,840 | 92,640 | $57,764,745 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
5 positions
15 tracked positions ·
$586,539,465 total
· filing declares
15 positions · $586,539,478
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BNTX |
BioNTech SE
Healthcare
|
Added | 754,550 | $70,210,877 | 11.97% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 1,932,904 | $68,405,472 | 11.66% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Added | 1,155,809 | $64,806,210 | 11.05% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 798,709 | $63,329,636 | 10.80% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 559,824 | $59,688,434 | 10.18% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 92,640 | $57,764,745 | 9.85% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Reduced | 1,191,522 | $34,411,155 | 5.87% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 113,085 | $34,041,977 | 5.80% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 118,975 | $32,295,763 | 5.51% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 446,059 | $23,939,986 | 4.08% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 858,753 | $23,169,155 | 3.95% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
NEW | 498,832 | $21,404,881 | 3.65% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
Added | 824,679 | $13,912,334 | 2.37% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Added | 464,920 | $10,497,893 | 1.79% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 468,666 | $8,660,947 | 1.48% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.